Monoamine oxidase inhibitors and anesthesia: an updated literature review
- PMID: 8237297
Monoamine oxidase inhibitors and anesthesia: an updated literature review
Abstract
Safe anesthesia for patients taking MAOIs has been possible since the 1980s using judicious choice of agents. The introduction of a new class of MAOIs (RIMA) has increased the margin of safety for these anesthetics. These drugs allow selective and rapidly reversible inhibition of type A-MAO. The pharmacologic effects of this new class of drug as well as their potential interactions with agents used in anesthesia are reviewed.
Similar articles
-
Studies of selective and reversible monoamine oxidase inhibitors.J Clin Psychiatry. 1984 Jul;45(7 Pt 2):62-6. J Clin Psychiatry. 1984. PMID: 6429130 Clinical Trial.
-
RIMA: a safe concept in the treatment of depression with moclobemide.Can J Psychiatry. 1992 Sep;37 Suppl 1:7-11. Can J Psychiatry. 1992. PMID: 1394030 Review.
-
[Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].Nervenarzt. 1996 May;67(5):339-47. Nervenarzt. 1996. PMID: 9005342 Review. German.
-
Clinical pharmacology of MAO inhibitors: safety and future.Neurotoxicology. 2004 Jan;25(1-2):215-21. doi: 10.1016/S0161-813X(03)00097-4. Neurotoxicology. 2004. PMID: 14697896 Review.
-
Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.J Psychiatry Neurosci. 1993 Nov;18(5):214-25. J Psychiatry Neurosci. 1993. PMID: 7905288 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical